Pharmacogenomics Market Analysis, Size, Regional Outlook, Share, Trend, Growth, Analysis and Forecast Report 2027
Market Size – USD 6.16 billion in 2019, Market Growth - CAGR of 8.7%, Market trends – Growing demand for personalized therapy.
The
research report provides an in-depth evaluation of the Global Pharmacogenomics
Market and helps the market participants intensify their footprints in the
industry. The report gives a detailed analysis concentrated on the critical
market dynamics such as drivers, restraints, trends, and growth opportunities
to assist businesses to prepare for any challenges they might encounter in the
forecast period. It also offers a regional analysis of the global Pharmacogenomics
market to explore possible growth prospects available in different parts of the
world.
The
competitive landscape is broadly evaluated alongside the company profiles of
key players engaged in the global Pharmacogenomics market. The report offers a
detailed statistical evaluation and accurate market data, viz., market share,
CAGR, gross margin, revenue, consumption, production, and sales.
Apart
from the above mentioned content the researchers go an extra mile to define the
distinct usage occasions and lists the customer segments to leverage the brand
and identify future opportunities. Besides, the subject matter expert segment
the target customers purely based on their consumption patterns.
For More Details
Get FREE Sample Pages of this Research Report@ https://www.emergenresearch.com/request-sample-form/88
Regional Analysis
The North American region holds the
largest spot in the growth of Pharmacogenomics market with a share of
approximately 52.6% in the year 2019 and is contemplated to hold the same by
the end of the decade due to constant growth of the construction industry of
Mexico, Canada, and the United States in the region.
Regional Scope: North America; Europe; Asia Pacific;
Central & South America; MEA
Key
participants include Abbott
Laboratories, Admera Health, LLC, Agena Biosciences, Inc., Cancer Genetics,
Inc., Dynamic DNA Laboratories, F. Hoffmann-La Roche Ltd, geneOmbio
Technologies Pvt Ltd., Genomic Health, Inc., Illumina, Inc., and Laboratory
Corporation of America Holdings, among others.
Get
Access to Full summary of this report @ https://www.emergenresearch.com/industry-report/pharmacogenomics-market
Product
and Services Outlook (Revenue, USD Billion; 2017-2027)
- Products
- Kits
- Assays and Reagents
- Instruments
- Software
- Services
- Genotyping
- SNP Identification
- Pharmacogenetic Testing
- Other Services
Technology
Outlook (Revenue, USD Billion; 2017-2027)
- Polymerase Chain Reaction (PCR)
- Real-Time PCR
- qPCR
- Digital PCR
- DNA Sequencing/Next Generation Sequencing (NGS)
- Nucleic Acid Amplification Tests (NAATs)
- Mass Spectrometry
- Gel Electrophoresis
- Hybridization
- Fluorescence In Situ Hybridization (FISH)
- Chromogenic In Situ Hybridization (CISH)
- Others
- Microarray
- Others
Application
Outlook (Revenue, USD Billion; 2017-2027)
- Oncology
- Infectious Diseases
- Neurology/Psychiatry
- Cardiovascular
- Others
End-Use
Outlook (Revenue, USD Billion; 2017-2027)
- Research Organization
- Pharmaceutical Companies
- Diagnostic Centers
- Others
Comments
Post a Comment